9:09 AM ET
8-K/A
Shareholder Meeting
Cumberland Pharmaceuticals Shareholder Meeting
Cumberland Pharmaceuticals reported that following its 2026 Annual Meeting, the Board of Directors determined to hold future advisory votes on executive compensation every three years. This decision aligns with the shareholder preference expressed during the advisory vote at the meeting.